Podcasts about nits

Programa nº 297 en el que nos visitan en directo la Dra. Inma Nicolas y Fran Calpe de Peña Zafra de Abajo; en directo vía teléfono tenemos a Noelia España que nos habla del espectáculo “Orquídeas” del 30 de marzo y a Benja Villegas que nos pone al corriente de la sesión de Nits de […] The post Los Tres Tenores 26/03/2025 first appeared on Ripollet Ràdio.

Radheshyam Das is a distinguished spiritual leader, educator, and author. An alumnus of IIT Mumbai, he graduated at the top of his class with an M.Tech degree. After working as a senior research fellow and as a mechanical engineer, he embraced monastic life in 1994, dedicating himself as a full-time brahmachari monk. In 1995, he was assigned to ISKCON Pune, where he has served as the Temple President for three decades, leading a vibrant community of approximately 6,000 members. In 2000, Radheshyam Das founded the Vedic Oasis for Inspiration, Culture, and Education (VOICE), a youth initiative aimed at imparting spiritual wisdom and cultural values to students and professionals. Under his guidance, VOICE has expanded to over 100 centers in India and more than 50 in Bangladesh, influencing thousands of young minds. A prolific author, he has compiled a five-volume series titled ‘Essence of Gita' and authored books such as ‘Stress to Smile' and the ‘Discover Your Self' series, which blend scientific and spiritual insights. His seminars on topics like stress management, proactive leadership, and time management have been well-received in academic institutions, including IITs and NITs, as well as in corporate settings. In 2012, he oversaw the establishment of the New Vedic Cultural Center (NVCC) in Pune, a landmark project featuring temples, guest accommodations, educational facilities, and community services. The center serves as a hub for spiritual learning and cultural activities, attracting visitors and devotees from around the world. Through his unwavering dedication, Radheshyam Das continues to inspire individuals globally, promoting a life enriched with devotion, knowledge, and compassion. Connect with Radheshyam Das: WEBSITE: https://radheshyamdas.com/ DISCOVER YOUR SELF VIDEO COURSE: https://www.youtube.com/watch?v=aDJ1jTu2dK8&list=PLQV_Ef4ahCVwkGBmEkHW3Z6RlMj7rryEs This event is hosted by ✨ Happy Jack Yoga University ✨ www.happyjackyoga.com ➡️ Facebook: /happyjackyoga ➡️ Instagram: @happyjackyoga Bhakti Yoga Conference at Harvard Divinity School Experience a one-of-a-kind online opportunity with 40+ renowned scholars, monks, yogis, and thought leaders! REGISTER FOR FREE: www.happyjackyoga.com/bhakti-... This conference is your opportunity to immerse yourself in the wisdom of sincere practitioners as they address the questions and challenges faced by us all. Expect thought-provoking discussions, actionable insights, and a deeper understanding of cultivating Grace in an Age of Distraction and incorporating Bhakti Yoga into your daily life.

Until the invention of DDT during World War 2 most humans expected to live with a range of lice as constant companions

Covering songs by the Nits isn't the easiest task, and neither is it one that has been often undertaken. For the 40th anniversary of the band, some Swiss Nits-enthusiasts thought it was high time to change the latter. The result: “Isnt Nits”, a 3 CD-box with 51 cover versions from artists from around the world.

Apple releases new iPhone 16e, Siri overhaul gets delayed again, Apple pledges 500 billion U.S. Investment including a factory in Texas. Apple TV app now on Android, speculation on what's coming to the Apple Watch Ultra 3 and Steve Jobs may soon be on a U.S. Coin. Plus the new trailer for Andor Season 2, updates on Notes and Journal apps and Only Murders in the Building Show.

Ashish Ranjan is an ex-ISRO, ex- BARC Scientist. He has spent the past 5 years writing a book on his experience of getting selected and working in India's Nuclear program and how he worked his way up into India's space program despite his poor academic background. Ashish had scored 53/100 in Mathematics and 61/100 in Physics on his 12th boards. He had even failed Physics in his 11th Standard. Ashish never got admitted to top universities for his B.Tech. like IITs or NITs. Yet, he made his way into India's two of the largest research organizations as a Scientist and got selected for Masters program in IIT Bombay. He has recently published a Book, "The Boy Who Did Not Sign" which is a fictional story inspired by a true event in Ashish's life in BARC and his road to securing an AIR-4 in ISRO national level Entrance Exam. The book is about pursuing a dream career despite our limitations and disadvantages, about relationship dynamics we all face, and about doing the right thing. The Boy Who Did Not Sign is now published worldwide (Paperback + eBook).–––––––––––––––––––

As usual with the Nits, another album means another approach. Gone are the more straightforward poppy structures of the two albums before this; “Malpensa” from 2012 is built on electronica and loops. 2014 is filled with celebrations for the 40th birthday which allows for a look back at history with a Best Of-box set and a second live album in 2015.

És el fenòmen de cada Carnaval, el Carrusel, l'espectacle de revista sitgetà dirigit per Marina Albadalejo i que per quart any consecutiu ha hagut d'ampliar els dies de representacions perquè la demanda va esgotar els dos primers dies, dijous gras 27 de febrer i dissabte 1 de març en poques hores. Per tant divendres 7 de març a les deu de la nit i dissabte 8 a les 20h el teatre del Prado tornarà a acollir el show Nits d'Estiu del Carrusel d'enguany. Després de mesos d'assajos intensificats en aquestes darreres setmanes ja és tot a punt en un any en que no han pogut comptar amb la col·laboració municipal amb les tarimes ni amb l'espai on poder treballar i guardar tot el material escenogràfic fet que lamenten i desitgen poder recuperar en properes edicions. N'hem parlat amb Marina Albadalejo, Àngel Lorenzo i la petita Lola, la més petita de l'elenc del Carrusel. L'entrada El Carrusel tornarà a omplir quatre dies el Prado amb el show Nits d’Estiu ha aparegut primer a Radio Maricel.

A petición popular, separamos la segunda parte de este capítulo para traeros un especial de las noches mágicas de Europa en el Camp Nou. La primera vez que eliminamos al Real Madrid de la Copa de Europa, el partido con el record de asistencia de espectadores, noches alegres, algunas con sabor agridulce por lo que sucedió jornadas más tarde, pero todas dignas de recordar y con las que esperamos que disfrutéis con nuestra narración. En este especial estamos acompañados de Carles Nicolau y Culé de Chamberí. Saga completa del culébron: https://www.ivoox.com/por-barca-solo-tiene-5-copas_bk_list_10210502_1.html Locutor y guión: Josep Vives Colaborador: Óscar Fernández Edición: Sagrario Pérez Queremos agradecer el apoyo de nuestros mecenas tanto de Ivoox como de Patreon. Por parte de Ivoox queremos dar las gracias a... Montimen Juaime Andrés Mateu Julian Perez Templado Ldg Escuchante Y por parte de Patreon queremos dar las gracias a los Medici: Óscar Fernández David Dacosta Andrade Fabián Gómez Xavier Boixeda Creixell César Ferrero Neira Julián Pérez Braojos Javier Perales Calvento Xavier Rondina Jorge Rubio Culé de Chamberi Carles Nicolau Coral Carlos Salavert Simón Daniel Arteaga Durán Gerard Rodríguez Juanjo Robles López Juan Antonio Cano Torres Jose Angel Giuseppe Gorka Esparza Barandiaran El heredero Julian Perez Templado Ldg Javier Moreno Gustavo Angulo Miki Amorós Agradecemos a nuestros mecenas todo el apoyo que nos brindan a través de Patreon, ¿quieres ser mecenas del canal? Accede al enlace y descubre todas las ventajas que tenemos para ti. https://www.patreon.com/golstalgia_ Recuerda que nos ayuda muchísimo a crecer y a que este video se pueda compartir en más plataformas, si das a ‘me gusta', compartes o nos dejas un comentario. Nuestras redes sociales: E-mail: golstalgia@gmail.com Twitter / X: https://x.com/golstalgia Youtube: https://www.youtube.com/@Golstalgia Ivoox: https://www.ivoox.com/podcast-golstal... Tik tok: https://www.tiktok.com/@golstalgia?la..

La vallesana Anna Andreu protagonitza el Disc de la Setmana, "Vig

El Parc del Nord es tancarà a les nits

Månen! Magisk. Mystisk. Har den været for mennesket i titusinder af år og er til dels stadig trods viden er ude af skabet. Trods den eneste anden "planet" vi har betrådt. 385.000 km fra jorden. Men med en kraft, der påvirker vandet i vore store oceaner. Selvom det stadig er uvist hvor meget den påvirker de store mængder vand i os? I modsætning til solen cirkulerer månen jo om jorden og selvom det tager ca. en måne(d), kan den "mystisk" nok ses fra ethvert åbent punkt på jord i døgnet (hvis skyfrit;). Månen har ikke bare fysisk, men stor symbolsk betydning for os jordboere igennem tiderne, omend selvfølgelig ikke så meget mere som for forfædrene (og mødrene;). Der bliver dog stadig skrevet sange om den gamle måne: Bat For Lashes, Cigarettes After Sex, Dali's Car, Depeche Mode, Duran Duran, The Doors, Echo & The Bunnymen, Electric Light Orchestra, Genesis, Claire Hamill, Rupert Hine, Billy Mackenzie, Nits, Police, Prefab Sprout, Ragga & Jack Magic, Sade, Yello og Lars Muhl + Susi Hyldgaard

Head lice, otherwise known as nits or kutis, is one of the most frustrating medical conditions parents have to face. It's very common and often seen in school outbreaks. What are head lice and who gets them? They're small insects found on the head. They live on hair and suck blood from the scalp. They lay eggs on the hair – looking like little grains of sand stuck to hair. Anyone can get them; it has nothing to do with poor hygiene. They do not carry disease. Only humans can get them, and they're spread through direct head contact. Often found on children who sleep together or play together. Often spread by school outbreaks. They can't live when not on the head and die quickly. How do you know you have them? Sometimes can see live insects moving on the scalp. Nits, headlice eggs look like small grains of sand stuck to hair that can't be brushed out: often found around the ears and back of the neck. Intense itch sometimes, kids often scratch at their hair. Scratching can cause sores to develop on the scalp. Often causes redness, swelling scalp. What do you do about them? Two things: You need to kill the live adult insects using a special shampoo and get rid of the eggs stuck to the hair. Use head lice shampoo ‘Dimethicone' twice, one week apart. It's not an insecticide, it suffocates the live head lice. You then have to comb out the eggs stuck to the hair, so they don't hatch. A few times every day for 1-2 weeks: use a fine-tooth nit comb, wet comb with the conditioner and comb till no eggs coming free. Any other things to think about? If one child gets infected in the family, check the rest of family and treat with shampoo on the same day. Tell your school – school outbreaks are common. It's difficult to prevent. Never ever use fly spray or kerosene (sometimes promoted): dangerous! LISTEN ABOVE See omnystudio.com/listener for privacy information.

Nueva entrega de Música de Contrabando, semanario de actualidad musical (30/1/2025)- Entrevistas: - Pignoise: Al frente de Pignoise está el ex futbolista del Real Madrid Álvaro Benito con el que hablamos, que compagina su agenda como comentarista con el resurgir de su grupo y, además, con un nuevo proyecto musical llamado Chicle.- Yayo Delgado nos presenta el ciclo "Sala de Bandas" protagonizado por grupos emergentes a lo largo de 2025- Manva Negra nos presenta su recién estrenado album, "Lucero". fusión de géneros con el folclore como base.- Noticias: Lynyrd Skynyrd gira 50 aniversario. Nick Cave anuncia gira en solitario. Bjõrk arremete contra Spotify. Se prepara rodaje película de Los Secretos. Supergrass y James, primeros nombres del Sonorama Ribera Day. Sony dejará de producir Blu-Ray. Toundra regresa con nueva formación. Vuelven las Nits de Barcelona. Semana del Benidorm Pop Fest. Black Grape gira 30 aniversario. Madrid Pop Fest completa su cartel. Los Planetas logran un top 10 con "Pop". Rush celebra 50 aniversario con una Super Deluxe Edition. Lady GaGa anuncia su nuevo álbum, Mayhem. - Novedades discográficas: Deacon Blue, Doves, Stereophonics, Jamie XX, Hope Tala, The Darkness, Japanese Breakfast, Horsegirl, Julian Baker & Torres, Divorce, Los Jaleo, Rata, Alec López, Karlan Malva, Circuit des yeux, Myriam Swanson, Fermi & María Rodés, Yawners, Verona, Niña Polaca & Dani Fernández, Lisasinson, Joy Orbison & Joe James, Craig Finn, Goblin Circus, The Wombats, Los Acebos, Danzón el Gato, Cabo Ventura, Uwade, Momma, La Texana, - Agenda de conciertos: Pignoise, Maestro Espada, Baiuca, Los Bengala, Santero y Los Muchachos, El Diablo de Shangai, Besmaya, Manva Negra, Sanguijuelas del Guadiana, Garaje Florida, Ropero, Nuria Culla, Los Recortables...

Headlice, also commonly known as nits, thrive in the warmer weather and often spread rapidly when kids return to school. But parents say they're hard to get rid of especially with the expensive cost of treatments, which means some families have resorted to drastic measures to get rid of them, like using flea treatment or shaving children's heads. Luka Forman has more.

The Nits are children of the Sixties. In 2008 and 2009, the Nits publish twin albums, that bear the influence of the period of classic pop music. These are shorter, upbeat songs, that still bear their own unmistakable mark. Back to the future!

We're back to recap a disappointing week of Penn State Basketball after the Nits fail to complete the comeback against the Hoosiers at the Palestra on Sunday afternoon. We'll also preview the first 2 of 3 consecutive ranked opponents Penn State will have to face and hope to defeat to get back into the NCAA tournament conversation. Support the showFollow us on X and Instagram @ShotsGottaFall Like us on Facebook at Shots Gotta Fall: The Penn State Basketball PodcastSend us an e-mail Shotsgottafallpod@gmail.comRate and review us and subscribe/follow Shots Gotta Fall wherever you download us every week!

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers the role of patient advocacy in replacing biopsy in clinical trials with NITs and reviews a session on the foundational principles for patien-centric clinical trials. This conversation picks up at the end of Michelle's discussion of the FDA Corner session. Jeff starts by identifying this specific issue - replacing biopsy in clinical trials with NITs - as a place topic on which he believes patients must play a pivotal role in this discussion. He notes that patient advocacy has been involved already but anticipates this role will grow as the discussion progresses. After Michelle agrees how vital this issue is for patients and notes that manufacturers are "taking on this increased workload" for that reason, Jeff shares what he considers the key issue: FDA is not only a scientific agency but also a political one, and patients can serve as the "tip of the spear" toward political ends here. Mike describes a poster he presented (and was lead co-author), titled Patient Voice in MASH Initiatives:  Foundational Principles for the Conduct of Patient-Centric MASH Research. He lists the groups participating in this broad effort and describes the goal as "reimagin[ing] clinical trials for MASH and how they're designed and delivered... focusing on what matters the most for patients." The outcomes were a set of patient-centric principles:Transparency in explaining trial-related issues. Mike gave the example of placebos, how they are used, and what happens to a patient in the placebo cohort at the end of the trial."Whole person focus," including not only the medical issues but also emotional and practical issues that can emerge throughout the trial as patients' needs and life situations change."Patients as partners," treating them as collaborators instead of subjects.Family and caregiver awareness, noting how deeply involved family members are through the trial process.Responsiveness to patient needs through surveys and checkpoints throughout the process.Mike closed his comments by stating that all these points "put the patient at the center of the process," which meant considering not only diversity and inclusiveness in the trial population but also knowing and acting on what diversity will be in the context of these five principles.Speaking from their perspectives as researchers, Michelle and Jörn were both highly supportive of the principles (Michelle called them "fantastic.") Jörn noted that the entire trial process starts with patient-centricity since the research is inherently designed to benefit patients.

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews two sessions promoting healthy livers and asks panelists what they anticipate for #TLM2025. This last conversation starts with Jeff describing the session that moved him most and praising a panel that Mike co-chaired on Lifestyle Management of MASLD and MASH. Jeff spoke on this panel, and he describes the breadth and quality of speakers and topics. While Jeff spoke about social determinants of health, others discussed commercial, regulatory and lifestyle determinants, all intermixed with practical advice on managing patients' lifestyle issues. Finally, he comments on a presentation from Meena Bansal discussing several concurrent posters in the meeting that aligned with the discussion in the session.  After Jeff shares the content of the meeting, he comments on the large number of providers and industry executives who attended this patient-centered session. Roger notes a similar distribution of attendees at the Health Livers, Healthy Lives session on building momentum for prevention. In wrapping up the session, Roger does not share another presentation but notes how many modes of action have produced successful Phase 2/3 trial results. He notes that we may have 4-5 different modes of action available five years from now. In the rest of the session, panelists describe what they believe will be different and exciting at #TLM2025. Answers vary, but most focus on advances in drug development and/or NITs.

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews the ESSENCE trial, the Phase 3 trial demonstrating that semaglutide regresses fibrosis levels in some MASH patients.  The conversation begins with each panelist sharing a word or short phrase they felt best captured their feelings about TLM2024. Next, panelists review the meeting's most consequential paper, the ESSENCE Trial. Naim starts by describing ESSENCE, a Phase 3 trial with semaglutide demonstrating significant levels of fibrosis regression in non-cirrhotic MASH patients. Jörn adds the hopeful note that NITs performed as well as or better than biopsy in this trial, which he hopes will speed the transition in diagnostic approaches and tools. Jeff and Mike agree that from the patient's perspective, ESSENCE will be seen as a milestone in MASH therapy: the proof that a second drug can succeed in MASH. As the conversation ends, Roger notes that approval of a second agent for a particular disease often leads to dramatic growth in overall drug treatment by changing the pivotal question from whether to treat with a drug to which choice to prescribe. 

Último espacio de 2024. Interesante programa en el que R.L. (Rafael López) descubre el gran secreto de la “Sorpresa del Nadal” de la Nits de Música del 3 de enero. Al acabar el programa, en la foto, el momento en el que, Inma Nicolás y Fran Calpe de Peña Zafra de Abajo (Murcia), nos entregan, […] The post Los Tres Tenores 18/12/2024 first appeared on Ripollet Ràdio.

On this weeks Podcast @jennyandmaireadnow Jenny gives us a history lesson in kissing. Mairead reviews some Christmas movies out now and we learn that Ties are in! More mobile phone chats about Beauty filers on TikTok and Barbie flip phones. A bit of a chat about family traditions and bringing back some 80's parenting - just say NO!! And we end on Orchid killing and the dreaded NITS!!Email us jennyandmaireadnow@gmail.com

A band is not only made up of musicians, there is a team behind them. In the case of the Nits, it is something akin to a family: a manager who has been there since the beginning, a sound engineer who grew up with them and a lighting engineer who has worked with them for years. This is the centre of operations, around which revolve many more people.

For the first time in a quarter century, Penn State is 6-0 to start the season! We talk all about how they got there and also preview the Sunshine Slam Championship against a good Clemson team. Will the Nits hoist only their second midseason tournament trophy of all-time? Support the showFollow us on X and Instagram @ShotsGottaFall Like us on Facebook at Shots Gotta Fall: The Penn State Basketball PodcastSend us an e-mail Shotsgottafallpod@gmail.comRate and review us and subscribe/follow Shots Gotta Fall wherever you download us every week!

It was a wild ride for the Nits on Wednesday night against the Mastodons but ultimately Penn State came out on the right side of the battle, remaining undefeated on the year. We talk about it including some thoughts on Mike Rhoades' post game comments. After that, we're joined by Fordham Rams Head Coach Keith Urgo to talk all things Sunshine Slam before Penn State matches up with its former assistant Monday evening. We preview the Rams and give our predictions for what should be a fun tournament before Thanksgiving. We'll be back on Monday night to preview the final game of the Sunshine Slam!Support the showFollow us on X and Instagram @ShotsGottaFall Like us on Facebook at Shots Gotta Fall: The Penn State Basketball PodcastSend us an e-mail Shotsgottafallpod@gmail.comRate and review us and subscribe/follow Shots Gotta Fall wherever you download us every week!

Facebook Marketplace Game, Two Topic Tuesday, Monday Winners and Losers, What Have You Googled, Fish Wars.. and NITS on the radioSee omnystudio.com/listener for privacy information.

Natalie Cassidy and Joanna Page chat about all things on and off the telly.This week Nat and Jo celebrate their boys getting through to Blackpool on Strictly, plus they catch up about the true crime drama Until I Kill You starring Anna Maxwell Martin and new rom com Nobody Wants This on Netflix.What they can't stop watching, what they definitely aren't going to bother with, new releases and comforting classics – TV is timeless and no telly is out of bounds.As well as having a natter about what's on TV, they share backstage goss from the world of telly, whilst also cracking up about the more humbling moments in their lives.Self-confessed TV addicts and stars of two of the biggest shows on our screens, EastEnders and Gavin and Stacey, Natalie and Joanna are the perfect companions to see what's occurring on and off the telly.Timecodes for shows discussed this week are:20:06 - Until I Kill You (ITVX) 26:42 - Nobody Wants This (Netflix)Get in touch by sending us a message or voice note via WhatsApp to 03306 784704.Hosts: Natalie Cassidy and Joanna Page Producer: Georgia Keating Executive Producer: Pete Strauss Commissioning Editor: Rhian Roberts Production Co-ordinator: Becky Carewe-Jeffries Sounds Editor: Arlie Adlington Music by MCassoOff The Telly is a BBC Studios Audio Production for BBC Sounds.

In this episode John Paul and Will discuss the amazing technology of FibroScan and other non-invasive test (NITs) in assessing the health of your liver. What is it, how and when to do it and what does it all me. Listen in to this episode to find out. Mail bag makes another visit. Don't forget to send questions to Liverhealthpod@gmail.com

Most poker players know about identifying Nits, tags and lags at the poker table. Buy here are 5 more player types you need to identify and exploit for max profits. 1) Street Poker Player Always looking for reasons to bluff or steal pots. They aren't fundamentally sound but they have an instinct for poker. When someone is weak etc. Can be tough to play if you let them move you off your game. 2) The Button clicker Takes a while to identify. But they will bet for no reason. Raise for no reason. All in for no reason. 3) Limp it all great and small They limp AA and 22. You will run into monsters with them and not know it until you identify them. You can't over play hands vs them. 4 and 5) Limp fold / Limp call The first limps any two but folds often to raises. The latter limps often and never folds to raises.

This is a special LIVE podcast, recorded at the awesome Big Feastival this summer. Our guest is Cat Sims, known on the socials as @notsosmugnow. We cover a host of topics in this podcast, from starting school to managing teens, coping with WhatsApp groups and dealing with nits. We chat about the three things you should never talk about with other parents, and have a heated debate about laundry. We bring back the classic game Handbag Surprise and of course we share some Scummy Mummy Confessions. There's even a cameo from a special guest at the end. And all in front of a live audience! In a tent! Huge thanks to Big Feastival for having us, and to Cat for being such a great guest - follow her on all the things @notsosmugnow, and check out her excellent honest baby book, The First Time You Smiled (Or Was it Just Wind?)*WE ARE ON TOUR!* Very soon we're coming to Hertford, Canterbury, Blackburn, Tenbury Wells, Newport, Norwich, East Grinstead, Harrogate, Newcastle... And then it's our Christmas tour! Go to scummymummies.com for dates and tickets. *WE HAVE A SHOP!* Visit scummymummiesshop.com for our ace t-shirts, mugs, washbags, sweatshirts and beach towels. FREE UK DELIVERY! We're on X (@scummymummies), Instagram, and Facebook. If you like the podcast, please rate, review and subscribe. Thank you for listening! Hosted on Acast. See acast.com/privacy for more information.

In todays episode we're joined by Luca McCabe from Boob to Food, who offers invaluable wisdom from her latest book “Toddler To Table” on transitioning toddlers to solid foods, complete with heartfelt anecdotes and practical tips. From navigating the minefield of picky eaters to establishing mealtime boundaries, we cover it all. Discover why consistent family meals matter and the secret to making mealtime less stressful without resorting to backup meals. Luka's insights into the importance of offering a variety of foods, including "safe" options, will change the way you approach the dinner table. Plus, we share our favourite simple recipes and strategies for efficient meal prep, ensuring you spend less time in the kitchen and more with your family. But the journey doesn't stop at food. We also explore the humbling, often messy realities of motherhood. From battling persistent NITS to navigating gastro outbreaks, Renee and Olivia's stories highlight the necessity of flexibility and a solid support system. Tune in to laugh, cry, and feel inspired as we share the indescribable, and sometimes unbelievable, moments that come with raising young kids. Get ready for an episode packed with heartfelt anecdotes and practical advice that every parent can relate to. Sponsor: Saba Organics https://www.sabaorganics.com Discount code for 20% off your first purchase: mumera Guest: Luka McCabe https://boobtofood.com Book: https://learn.boobtofood.com/product/toddler-to-table/ Connect with Luka @boobtofood @lukamccabe Connect with Mum Era Podcast  Email: ⁠hello@mumerapodcast.com⁠  Website: ⁠mumerapodcast.com⁠  Instagram:  ⁠@mumerapodcast⁠  Connect with Renee:  Instagram:  ⁠@reneebargh⁠  Connect with Olivia:  Instagram: ⁠@oliviajdavies⁠

Tune in every week on Sundays to hear more on the madness and don't be afraid to share your hilarious life stories with us on @tendownpodcast on instagram see links below!!Follow us on: https://www.instagram.com/tendownpodcast/ Terrie: https://www.instagram.com/terriemcevoy/ David : https://www.instagram.com/davidfitz1986/

00:00:00 - Surf's Up: Season 5 Episode 25 On July 20, Clinical Gastroenterology and Hepatology released the paper, Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients with MASH/NASH and Moderate to non-cirrhotic Advanced Fibrosis. Corresponding author Maru Rinella joins the Surfers to share key points from the recommendations and offer her thoughts on what lay behind them.00:02:26 - Introduction and GroundbreakerThe highlight was Louise's groundbreaker: having become a full Fellow in the Roal College of Physicians.00:06:28 - Introducing the paperRoger starts by discussing the importance of this paper and listing the questions the panel will address during the episode. Maru provides a history of developing the paper. Jörn praises its timeliness. 00:08:59 - Treating the "Right" patients; Using the "Right" testsJörh asks why the authors changed the patient definition from a histological one to at-risk MASH patients confirmed by NITs. Maru said the authors sought to follow the FDA guidance on NITs and patient targets. They considered adding liver enzymes or confirmatory VCTE to the protocol, but demurred because not every clinical could execute such a recommendation. Jörn asks whether the authors considered requiring three metabolic risk factors. Roger notes that this question implies a need to prioritize patients, which is a factor in Europe but not the U.S. This paper takes a more U.S-based perspective, which is to set a threshold for use.  00:14:21 - The Decision Not to Discuss CostThe authors did not address costs because they anticipated steep reductions over time. The panel compares the MASH case to HCV. In HCV, the combination of high drug costs and large number of warehoused patients drove prioritization over time. 00:16:34 - Relative paucity of warehoused MASH patients Maru suggests relatively few MASH patients are warehoused. Louise asks whether many U.S. insurers are controlling access by requiring liver biopsy. Maru reports she has not encountered this personally and  estimates it might affect ~5% of cases so far. 00:19:05 - Rationale for Patient SelectionMaru explains the rationale for an F2 threshold for patient selection: patients with fibrosis >= F2 show a demonstrable decline in long-term survival. The rationale for excluding cirrhosis patients? Resmetirom is not yet proven to help patients with cirrhosis. Jörn notes, the MAESTRO-OUTCOMES trial is running and will generate consequential data on cirrhosis. 00:22:11 - Value of Stabilizing Disease without ImprovementMaru notes that the paper focused strongly on how to stabilize patients because the drug is safe and stabilization has real-world benefits.. She points out that patient advocates strongly recommend this focus. All this led to the paper's recommendation to discontinue only upon progression.  00:25:12 - The importance of incremental learningThe group agrees that these recommendations comprise a base that will be strengthened over time as individual providers gain experience with the drug. 00:30:06 - Wrapping upPanelists touch briefly on the value of loose discontinuation rules, how patients feel about starting therapy, how to handle drug interactions, and how the paper is used in the US vs. other countries. In closing, the group remembers Stephen Harrison's unique contributions one more time.00:37:55 - Question of the WeekWhich of the paper's two striking recommendations -- using multiple NITs to qualify patients and continuing therapy unless and until a patient shows signs of disease progression -- will have greater impact on how physicians treat patients?00:38:44 - Business ReportSummer schedules, value of the business report, the vault discussion.

Amanda Prowse and Penny Dommett nattering around the kitchen table, chatting about all things random. Penny's arrival wearing bugs!  When the kids get nits – how times have changed, remember the nit nurse? Is it true that nits only like clean hair? Do carrots really help you see in the dark? Penny's plum adventures with Pippin, and memories of Pippin as a pup eating the kitchen! Hear us improvise our own hold music… Mandy's love of Hey Dougie! (and Penny's hatred of it!) Swimming To Lundy – Mandy's new novel is out in the world. Penny's planting style and how she builds a garden. Did you know Penny's got two acres?? Advice on planting out your Hydrangeas and how and when to water your garden and plants! Penny's says ditch the spray head on your hose, who knew? And Mandy's weight loss journey…So, pull up a chair and join us for a delightfully irreverent chit chat about life and all its random tangents - bring a cuppa. Cake optional...

This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. Before answering the question, Matt describes the core services his company offers: "PharmaNest specializes in digital pathology. Four years ago, we put down the hypothesis that the histological phenotype of fibrosis should be quantified in a high-resolution, sophisticated way." He goes on to state their core proposition for MASLD: "The big idea here is that fibrosis equals phenotype." He proceeds to describe his offerings in greater detail before offering the underlying value of computed histology: fibrosis is a continuous variable that is scored in discrete categories under the NASH-CRN model that drives FDA analysis. With this as context, he answers the question by describing three kinds of MASLD clinical trial designs. The first, earliest trials had a single pathologist reading histological slides. The method is not precise, but the drugs were not very good, and none were ultimately approved. The second set of trials relied on more rigorous methods for pathologists to read histology slides, with multiple readers and robust adjudication systems. Also, the drugs in this second set of trials were more efficacious, so that NASH-CRN, while a blunt instrument, could adequately assess efficacy. For the third set of trials, Matt believes non-invasive tests (NITs) are likely to suffice.

#173: Lorenzo Romar is one of college basketball's all time winningest and most accomplished coaches. More importantly he is one of the most respected coaches. He has served as the head coach at the University of Washington, Pepperdine, and Saint Louis. He is currently an assistant coach a Loyola Marymount University. As a head coach, he's had 18 players taken in the NBA Draft. As either a head coach or an assistant, he's worked with 27 future NBA Draft picks. During his time in Washington alone he coached several future NBA players including Brandon Roy, Nate Robinson, Isaiah Thomas, Quincy Pondexter, Spencer Hawes, and top-overall pick Markelle Fultz.As the Head Coach of Washington, the Huskies played in six NCAA Tournaments, three NITs and one CBI, and won 298 games. Additional accolades in Romar's decorated career include winning the Pac-10/Pac-12 regular season twice (2009, 2012), winning the Pac-10/Pac-12 Tournament three times (2005, 2010, 2011), being named Pac-10/Pac-12 Coach of the Year three times (2005, 2009, 2012), and winning the Conference USA Tournament (2000).Coach Romar was drafted in the 1980 NBA Draft and played 5 seasons in the NBA with the Warriors, Bucks, and Pistons.He started at Cerritos Community College and then went on to play at Washington, where he was a two-year starter at point guard and was the team captain as a senior.On the show Coach Romar shares his story of growing up in Compton, influence of his parents, his love for basketball, resilience, playing in the NBA, Athletes in Action, getting into coaching, faith, family, values, and much more.As I was getting into coaching Coach Romar was one of the main coaches I wanted to learn from and I spent a tremendous amount of time just to have the opportunity to be around him and his program. He gave me some of the best advice during my coaching journey. One of the men I respect the most not only for the success that he has had, but the type of person that he is. I'm excited to share his story with you all. Enjoy the show! 

00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre,  followed by a discussion with patient advocates Mike Betel of the Fatty Liver Alliance and José Willemse from the Netherlands, now supporting EASL. 00:02:45 - IntroductionRoger explains the episode format, including the two key questions for Mathieu and Jeff: (i) what were their key takeaways from the EASL Congress, and (ii) how have those takeaways changed how they do their jobs or plan for the future? Roger also sets up the Question of the Week discussion that is today's third section. 00:04:04 - Meet Mathieu PetitjeanThis is the SurfingMASH debut for Mathieu Petitjean, Founder and CEO of PharmaNest. He tells the audience a bit about his background and his love of Harleys.00:07:10 - First question to MattMatt begins by describing the core services Pharmest, a digital pathology company, offers MASH drug developers. Then he answers Roger's question by describing three phases in MASLD clinical trial designs. His point is that over time, drugs have gotten better, and histology requirements have become more onerous. At some point in the not-too-distant future, Matt believes non-invasive tests (NITs) are likely to suffice in large Phase 3 trials of the future.00:21:01 - Second question to MattMatt starts the answer with a conditional: if biopsy-based analyses become part of a surrogate endpoint, the role is large and clear. If not, they are unlikely to remain relevant in Phase 3 trials. Regardless of the answer to this question, Matt believes digital pathology will remain important in pre-clinical work and in other continuous liver diseases with less-defined targets. Also, he says, digital pathology is valuable in an array of non-hepatological markets, notably including pathology. 00:29:11 - First question to JeffJeff describes an "overriding sense of optimism" he felt due to the many positive drug trials presented in Milano. This suggests that the MASLD community is developing safe and effective MASH drugs with many different modes of action. This is allowing GLI and other advocates to start to have "more enlightened discussions" about MASLD in the context of the patient's overall metabolic state. All this means that what works in one patient might not in another. This can reshape clinical trials so that the endpoint target might not be change in fibrosis but impact against specific NIT targets. Jeff envisions this line of inquiry as a possible step away from biopsy. 00:39:34 - Second question to JeffConcurrently, FDA is beginning to require greater diversity in clinical trial populations. To Jeff, all this makes patient advocates like GLI more valuable to the clinical trial design process and pivotal in ensuring that metabolic and advanced MASH patients will still get the drugs they need. Starting today, Jeff sees advocates as championing underserved groups in the population while at the same time laying the foundation for the longer-term case. 00:55:20 - Discussing previous "Question of the Week"This is a 15-minute discussion of the Question of the Week we posed at the end of S5 E23. This section will constitute S5 E24.5, which we will post in the next day or two. A more complete summary will appear there. 01:11:23 - Question of the WeekThe Question of the Week is the first question Roger asks Matt and Jeff during this episode.01:12:58 - Business ReportPreviewing Episode 25, with Maru Rinella discussing the recently-published expert recommendations on use of resmetirom, along with comments on office hours the reason we will not have a vault conversation this week.

Matt has a new household member who is laying eggs in not only his children's hair but also his own.  Ash's oldest son, Oscar, finds a new friend in Siri, but just like all friendships, this one comes with its highs and lows. Plus! Nanna Johnson answers your questions:  How do you handle tantrums? Should you raise boys and girls differently? Make sure you share your best Petty Couples stories with us

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to focus on the role FGF-21s will play in long-term advanced fibrosis treatment: induction or long-term therapy...or might we even think of the class as being able to produce a "MASH cure?" Responding to Naim's comment closing the previous discussion, Mazen questions why we regard FGF-21 agents as induction therapies given that it appears to be as well tolerated as the oral agents and maintains such efficacy over time. In fact, he adds, its sustained efficacy might make it possible for livers to eliminate fibrosis and return to their "normal" state, almost like a "cure." Jörn adds a comment about pegozafermin, another FGF-21 in development. Jörn notes that this agent is a pegylated molecule, which makes it different from efruxifermin. He notes that NITs show sustained enzyme response at 48 weeks. Mazen reiterates his optimism about the FGF-21 class and reminds us that there is a third FGF-21 in development. Roger raises Michael Charlton's question (Season 5 Episode 11) whether an induction therapy strategy for FGF-21s might not work if removing the drug allows the MAS activity to return. On the other hand, he notes, it might take years for fibrosis to return. Mazen agrees that many unanswered questions exist, but reiterates his belief in long-term therapeutic value.  

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss some of the other major drug development stories from the EASL Congress 2024, with special focus on denifenstat, ION-224 and TAK-227, and to review the SPECIAL study on bariatric surgery and cirrhosis. The panelists concur that all three of these agents have potential value in therapy. Naim expresses some concern about how broad denifestat use will be based on its side effect profile. Later in this conversation, Mazen belives that denifenstat has broad potential for use, given that the most prominent side effect, hair thinning, appears transient and readily manageable. He also notes that denifenstat's impressive results were based on Intent to Treat analysis, which is more rigorous.  Naim states his interest in the ION-224 agent based on its mode of action, which is RNA interference. He also discusses SPECIAL, a study he conducted with the bariatric surgery group at Cleveland Clinic. This study, which evaluated patients with cirrhosis at the time of surgery, demonstrated a 72% risk reduction in major adverse liver outcomes over a 10-year period and 80% risk reduction in decompensation. Jörn discusses a study he presented on TAK-227, a TG2 inhibitor originally developed for celiac disease. Early results here are quite promising and, as Aleksander Krag mentioned in S5 E17, demonstrates exciting potential for collaboration with drug developers for other diseases. As the conversation ends, Roger asks Mazen and Jörn what they consider likely to be the biggest MASLD stories at the AASLD Liver Congress in November. Mazen selects the Phase 3 ESSENCE study for semaglutide, while Jörn suggests NITs. 

Who do you turn to on the tough days of parenting? When you're stuck in the trenches a phone call, a play date, or a coffee catch-up can be like oxygen. Today, in this brand new chapter of This Glorious Mess, hosts Annaliese Todd and Tegan Natoli kick things off with a shout-out to the village. The people in your community who lift you up, spark joy, and sit with you through the tough moments. We also welcome a very special new friend, Sarah Marie Fahd. She's here to help, or at the very least, let you vent out your parenting problems. Plus, we introduce a new kind of recommendation, the essential items you might need to add to your parenting toolkit to help fill your cup. THE END BITS  Got a message for Sarah Marie? We're listening! Send us a voice message, email us at tgm@mamamia.com.au Tell us what you really think so we can give you more of what you really want. Fill out this survey and you'll go in the running to win one of five $100 gift vouchers. Subscribe to Mamamia We've compiled all the best resources for new mums in a free newsletter. Join the mailing list. CREDITS: Host: Tegan Natoli, Annaliese Todd & Sarah Marie Fahd  Producer: Grace Rouvray Audio Producer: Lu Hill Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander cultures.Become a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

Marjorie, Britni, and Goodwin discuss the logistics of the final battle, who the traitor is, and what they'll do with their lives when the series is over.As always, thank you Yellowis4happy for our podcast artwork. Find more at yellowis4happydraws on Tumblr or shannonannedraws on Instagram. Also thank you to Thomas Dick for our music. Find more on his Soundcloud page. Hosted on Acast. See acast.com/privacy for more information.

This first conversation from our EASL Congress 2024 preview starts with EASL Secretary General Aleksander Krag offering his vision for next week's meeting in Milano, after which Hannes Hagstrom shares some of his thoughts about the meeting design. Aleksander starts by discussing the preparation that has gone into this Congress since the Vienna meeting closed last August. The goals are ambitious, but he feels EASL has, by and large, succeeded. Aleksander mentions that 7,000+ people have registered, including 80+ companies and 25+ patient groups.  and that researchers submitted 3,000 abstracts, 2,000 of which have been accepted. "Almost 300 different types of sessions" with 450 faculty members focus on: The one approved MASLD drug and nine others in late-stage development, including "several Phase 2 studies"Breakthroughs on non-invasive tests An update on the "one-year baby" nomenclature, including a look at alcohol in the context of ALD and MetALDEnhanced understanding of the underlying disease.He also highlights the EASL Studio as a "relaxed" place to listen to important discussions. Finally, he praises Milan's charms, particularly its food and wine. Hannes describes the scale of the program as "like going to a place with a lot of good restaurants, but you only have one stomach," with not only research presentation sessions but also an array of meetings. He also commends the design element that places young researchers in prominent positions. Aleksander notes that some choices of chairs and events are designed specifically to move the public dialogue beyond "the usual suspects." 

Everyone has faced this problem of lice at least once in their life, be it with their kids or themselves or someone close to them. Beating lice and getting rid of nits is not that hard as per our host Ilene Steinberg who takes pride in providing easy to do solutions to people for getting rid of lice and nits. Today, we have a special guest on the podcast – ⁠Ilene Steinberg⁠, also known as "⁠The Lice Queen.⁠" As the Founder and CEO of the Center for Lice Control, she's on a mission to educate the public and eradicate head lice in the U.S., boasting over 20 years of hands-on experience in treating and preventing lice infestations. Watch our podcast to learn about methods that you can utilize to get rid of lice and nits and give your hairs a breathing room that it deserves. It's time to save yourself from the embarrassment of having lice in your hairs. Time Stamps: 1:20 How can parents easily identify and prevent head lice in their children? 6:40 What are some common misconceptions about head lice, and how can the public be better educated about them? 10:05 Could you share some practical tips for schools and sports teams to effectively manage and prevent head lice outbreaks? 12:50 In your experience, what are the most effective and safe lice treatment products that parents can use at home, without resorting to pesticides or harsh chemicals? 17:50 PowerMom Chronicles 18:05 What's a game-changing lesson life has taught you? 19:55 Reflecting on your journey, what practical lesson or insight can our listeners apply to improve their lives? 20:40 Offer a piece of wisdom for moms striving to find their strength and voice. 21:40 Best advice you've ever received? Connect with Ilene: TWITTER: https://twitter.com/ileneoldaccount INSTAGRAM: https://www.instagram.com/ilenethelicequeen/ FACEBOOK: https://www.facebook.com/ilene.steinberg/ YOUTUBE: https://www.youtube.com/channel/UCSYgsTrsldiTsNe4dZZUXoQ Check Cristina Out: Blog: https://cristinafrancy.com/ Instagram: @notyourmommas.podcast Amazon Store Front: https://www.amazon.com/shop/notyourmo... Email for collaborations: hello@notyourmommaspodcast.com --- Support this podcast: https://podcasters.spotify.com/pod/show/thefrancylife/support

We assume would be the slogan for the 'super nits' that have taken over Sydney schools these past weeks. This week we heard some of the wild things your kids have said in public and of course we cannot forget the nicknames you have for your neighbours. We have Wippa shaving "Bond" into his chest, Vagina Wall art installations, first kiss fails and of course, Kate's backend gets its time in the limelight for Out of Context Kate...See omnystudio.com/listener for privacy information.

Rounding out your week with Mother's Day Shout Outs, Timewaster, Knock Off Friday, and lots more!See omnystudio.com/listener for privacy information.

Podcast #692 stacks 'em deep and likes 'em cheap with blowouts from Steve Conte, Bottle Breakers, The Reflectors, The Yum Yums, Billy Tibbals, The Luxury Item, Go Generation, Itchy and The Nits, & Tyr.

Vijftig jaar geleden speelde Henk Hofstede voor het eerst met zijn band The Nits. En dat doet hij nog steeds. Ook al is hun werkplek in Amsterdam twee jaar geleden volledig afgebrand en heeft hij af te rekenen met een lastige spierziekte. Waar haalt hij zijn veerkracht vandaan? Hoe moeilijk is het om origineel te zijn in de muziekwereld en welke invloed hebben vrouwen op hem?

episode #762. listening to songs from early may 2020. this was a month after bandcamp fridays started, so it seems like folks were sharing random collections of demos and such that they took down later. anyway, i have them and will enjoy them :) thank youDOWNLOAD/STREAM RECORDING00:00 (intro by omar)00:20 No Ditching "Song for Shelley" Inseparable02:40 Mia Joy "Paradox" Gemini Moon EP08:17 Concrete Lawn "MILK" AGGREGATE11:12 Silicon Heartbeat "Atomic Experiments For Boys" Q3212:31 Becca Mancari "Waiting So Long" Good Woman15:16 CS Luxem "Front Porch" SeedCo Demos18:43 PowPig "Sticky Teeth" Denture Adventure21:11 Pure X "Free My Heart" Pure X24:23 Powerplant "A Spine" A Spine / Evidence27:30 guests "Dragon" Fat Cat Residency Demos 2015 - 201930:21 Wendy Eisenberg "history time" Dehiscence33:38 Bad History Month "DON’T U 4GET ABOUT ME?“ Nu BLuS _ BuRNT AND MELTED VERSIONS36:36 Campfires "She Was Down" Stormy Late Fall EP39:32 Charmaine’s Names "Quiet Fire" Surname43:38 Trying "Dog Videos" I Won’t Let You Lose the Rhythm45:00 Hello Shark "Stars are Glow" Rarities 2006-202047:30 Sniffany and the Nits "Horse Girl" The Greatest Nits49:35 Sauna Youth "Decisions" In Flux51:59 VAIL "THE MIRROR" MUSIC FOR BUTTERFLIES54:08 Grumpster "Roots" Underwhelmed

Lexicographer, author and Dictionary Corner resident Susie Dent has been studying words to make us feel happy. She brings etymologies concerning cows, gas, guts and fat, of bellies and breathing and bonanzas. And some that came from the high seas and aren't made up! Find out more about this episode and the topics therein, and obtain the transcript, at theallusionist.org/siblings-of-chaos. Become a member of the Allusioverse at theallusionist.org/donate and as well as keeping this independent podcast going, you get regular livestreams and watchalong parties - AND to hang out with your fellow Allusionauts in our delightful Discord community. We'll be watching the new season of Great British Bake Off together, starting Tuesday 26 September 2023. Our ad partner is Multitude. If you want me to talk lovingly and winningly about your product or thing, sponsor an episode: contact Multitude at multitude.productions/ads. This episode is sponsored by: • Bombas, whose mission is to make the comfiest clothes ever, and match every item sold with an equal item donated. Go to bombas.com/allusionist to get 20% off your first purchase. • Ravensburger, who make jigsaw puzzles for ages toddler to ancient and piece preferences from two to 40,000!• Squarespace, your one-stop shop for building and running your online empire. Go to squarespace.com/allusionist for a free 2-week trial, and get 10 percent off your first purchase of a website or domain with the code allusionist. • HelloFresh, America's number 1 meal kit - pre-portioned farm-fresh ingredients and seasonal recipes delivered right to your door. Go to HelloFresh.com/50allusionist and use the code 50allusionist for 50% off plus 15% off the next 2 months.Support the show: http://patreon.com/allusionistSee omnystudio.com/listener for privacy information.